S17 | OMALIZUMAB SYMPOSIUM |
S18 | Unmet need in inadequately controlled asthma |
S22 | Weak link in the lung |
S29 | Omalizumab (Xolair) in patients with steroid-resistant asthma: Lessons to be learnt |
S35 | Use of omalizumab in a severe asthma clinic |
S45 | QUESTION AND ANSWER SESSION |